These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16378654

  • 1. Enhanced anti-fibrotic activity of plasmid DNA expressing small interference RNA for TGF-beta type II receptor for a mouse model of obstructive nephropathy by cationized gelatin prepared from different amine compounds.
    Kushibiki T, Nagata-Nakajima N, Sugai M, Shimizu A, Tabata Y.
    J Control Release; 2006 Feb 21; 110(3):610-7. PubMed ID: 16378654
    [Abstract] [Full Text] [Related]

  • 2. Delivery of plasmid DNA expressing small interference RNA for TGF-beta type II receptor by cationized gelatin to prevent interstitial renal fibrosis.
    Kushibiki T, Nagata-Nakajima N, Sugai M, Shimizu A, Tabata Y.
    J Control Release; 2005 Jul 20; 105(3):318-31. PubMed ID: 15936840
    [Abstract] [Full Text] [Related]

  • 3. Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds.
    Kushibiki T, Tomoshige R, Iwanaga K, Kakemi M, Tabata Y.
    J Control Release; 2006 May 15; 112(2):249-56. PubMed ID: 16545479
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. TGF-beta1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction.
    Hwang M, Kim HJ, Noh HJ, Chang YC, Chae YM, Kim KH, Jeon JP, Lee TS, Oh HK, Lee YS, Park KK.
    Exp Mol Pathol; 2006 Aug 15; 81(1):48-54. PubMed ID: 16443218
    [Abstract] [Full Text] [Related]

  • 7. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
    Kondo T, Takemura G, Kosai K, Ohno T, Takahashi T, Esaki M, Goto K, Maruyama R, Murata I, Minatoguchi S, Fujiwara T, Fujiwara H.
    Clin Exp Pharmacol Physiol; 2008 Nov 15; 35(11):1288-93. PubMed ID: 18505441
    [Abstract] [Full Text] [Related]

  • 8. In vitro transfection of plasmid DNA by cationized gelatin prepared from different amine compounds.
    Kushibiki T, Tomoshige R, Iwanaga K, Kakemi M, Tabata Y.
    J Biomater Sci Polym Ed; 2006 Nov 15; 17(6):645-58. PubMed ID: 16892726
    [Abstract] [Full Text] [Related]

  • 9. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice.
    Yang J, Dai C, Liu Y.
    Gene Ther; 2001 Oct 15; 8(19):1470-9. PubMed ID: 11593360
    [Abstract] [Full Text] [Related]

  • 10. The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-beta type II receptor gene transfer.
    Motomura Y, Kanbayashi H, Khan WI, Deng Y, Blennerhassett PA, Margetts PJ, Gauldie J, Egashira K, Collins SM.
    Am J Physiol Gastrointest Liver Physiol; 2005 Jan 15; 288(1):G143-50. PubMed ID: 15297261
    [Abstract] [Full Text] [Related]

  • 11. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W, Wang LW, Shi JZ, Gong ZJ.
    Hepatobiliary Pancreat Dis Int; 2009 Jun 15; 8(3):300-8. PubMed ID: 19502172
    [Abstract] [Full Text] [Related]

  • 12. Targeting of plasmid DNA to renal interstitial fibroblasts by cationized gelatin.
    Kushibiki T, Nagata-Nakajima N, Sugai M, Shimizu A, Tabata Y.
    Biol Pharm Bull; 2005 Oct 15; 28(10):2007-10. PubMed ID: 16204967
    [Abstract] [Full Text] [Related]

  • 13. Complement C5 mediates experimental tubulointerstitial fibrosis.
    Boor P, Konieczny A, Villa L, Schult AL, Bücher E, Rong S, Kunter U, van Roeyen CR, Polakowski T, Hawlisch H, Hillebrandt S, Lammert F, Eitner F, Floege J, Ostendorf T.
    J Am Soc Nephrol; 2007 May 15; 18(5):1508-15. PubMed ID: 17389734
    [Abstract] [Full Text] [Related]

  • 14. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin.
    Kushibiki T, Matsumoto K, Nakamura T, Tabata Y.
    Gene Ther; 2004 Aug 15; 11(15):1205-14. PubMed ID: 15103321
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression profile of plasmid DNA by spermine derivatives of pullulan with different extents of spermine introduced.
    Jo J, Ikai T, Okazaki A, Yamamoto M, Hirano Y, Tabata Y.
    J Control Release; 2007 Apr 23; 118(3):389-98. PubMed ID: 17320235
    [Abstract] [Full Text] [Related]

  • 19. Enhanced ectopic bone formation using a combination of plasmid DNA impregnation into 3-D scaffold and bioreactor perfusion culture.
    Hosseinkhani H, Yamamoto M, Inatsugu Y, Hiraoka Y, Inoue S, Shimokawa H, Tabata Y.
    Biomaterials; 2006 Mar 23; 27(8):1387-98. PubMed ID: 16139884
    [Abstract] [Full Text] [Related]

  • 20. Preparation of poly(ethylene glycol)-introduced cationized gelatin as a non-viral gene carrier.
    Kushibiki T, Tabata Y.
    J Biomater Sci Polym Ed; 2005 Mar 23; 16(11):1447-61. PubMed ID: 16370244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.